PubMed · 2014 · 26 citations · 37 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerApoptosis PharmacologyApoptosis RegulationCell Cycle PharmacologyLaryngeal CancerAnticancer ActivityCancer Cell ApoptosisCancer Cell Proliferation InhibitionCell Cycle DynamicsCell Cycle InhibitionCell Viability AssaysQuantitative Polymerase Chain Reaction AssaysS/g2 Transition
BACKGROUND: The aim of the present study was to determine the effects of osthole on cell proliferation and viability, cell-cycle progression and induction of apoptosis in human laryngeal cancer RK33 and human medulloblastoma TE671 cell lines. MATERIALS AND METHODS: Cell viability was measured by means of the MTT method and cell proliferation by the 5-bromo-2-deoxyuridine (BrdU) incorporation assay. Cell-cycle progression was determined by flow cytometry, and induction of apoptosis by release of oligonucleosomes to the cytosol. The gene expression was estimated by a quantitative polymerase chain reaction (qPCR) method. High-performance counter-current chromatography (HPCCC) was applied for isolation of osthole from fruits of Mutellina purpurea. RESULTS: Osthole decreased proliferation and cell viability of cancer cells in a dose-dependent manner. The tested compound induced apoptosis, increased the cell numbers in G1 and decreased cell number in S/G2 phases of the cell cycle, differentially regulating CDKN1A and TP53 gene expression depending on cancer cell type. CONCLUSION: Osthole could be considered as a potential compound for cancer therapy and chemoprevention.
37
Jarogniew J. Łuszczki, Ewa Wojda, Marta Andres‐Mach et al. · Epilepsy Research · 2009 · 132 citations
Medicine, Neuroscience, Pharmacology +11